KGC vs. AXSM
KGC (Kinross Gold Corporation) and AXSM (Axsome Therapeutics, Inc.) are both stocks. KGC operates in Gold (Basic Materials), while AXSM operates in Biotechnology (Healthcare). Over the past 10 years, KGC returned 16.68%/yr vs 39.83%/yr for AXSM. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
KGC vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KGC achieves a -17.75% return, which is significantly lower than AXSM's 19.36% return. Over the past 10 years, KGC has underperformed AXSM with an annualized return of 16.68%, while AXSM has yielded a comparatively higher 39.83% annualized return.
KGC
- 1D
- -2.20%
- 1M
- -1.58%
- 6M
- -26.61%
- YTD
- -17.75%
- 1Y
- 45.18%
- 3Y*
- 71.30%
- 5Y*
- 30.97%
- 10Y*
- 16.68%
- ALL TIME*
- 4.99%
AXSM
- 1D
- -7.10%
- 1M
- -9.42%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 115.02%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
| $162.18M | $178.21M | $212.46M |
KGC vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KGC Kinross Gold Corporation | -17.75% | 206.11% | 55.63% | 51.83% | -27.59% | -19.00% | 56.04% | 46.30% | -25.00% | 38.91% |
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
Correlation
The correlation between KGC and AXSM is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.16 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.10 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.09 |
Fundamentals
KGC:
$27.58B
AXSM:
$11.22B
KGC:
$2.61
AXSM:
-$3.72
KGC:
3.32
AXSM:
15.58
KGC:
2.86
AXSM:
204.46
KGC:
$8.39B
AXSM:
$708.24M
KGC:
$4.50B
AXSM:
$655.82M
KGC:
$5.58B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KGC vs. AXSM — Risk / Return Rank
KGC
AXSM
KGC vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kinross Gold Corporation (KGC) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KGC | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.82 | ||
| Sortino ratioReturn per unit of downside risk | -2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.47 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.12 | 6.25 | -5.14 |
| Martin ratioReturn relative to average drawdown | 2.49 | 18.02 | -15.53 |
Loading charts...
Drawdowns
KGC vs. AXSM - Drawdown Comparison
The maximum KGC drawdown since its inception was -96.00%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for KGC and AXSM.
Loading charts...
Drawdown Indicators
| KGC | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.00% | -86.65% | -9.35% |
Max Drawdown (1Y)Largest decline over 1 year | -40.66% | -18.50% | -22.16% |
Max Drawdown (3Y)Largest decline over 3 years | -40.66% | -32.69% | -7.97% |
Max Drawdown (5Y)Largest decline over 5 years | -55.22% | -61.08% | +5.86% |
Max Drawdown (10Y)Largest decline over 10 years | -67.75% | -81.26% | +13.51% |
Current DrawdownCurrent decline from peak | -39.16% | -14.57% | -24.59% |
Average DrawdownAverage peak-to-trough decline | -57.51% | -39.06% | -18.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.22% | 6.41% | +11.81% |
Volatility
KGC vs. AXSM - Volatility Comparison
The current volatility for Kinross Gold Corporation (KGC) is 12.31%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that KGC experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KGC | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.31% | 14.94% | -2.63% |
Volatility (6M)Calculated over the trailing 6-month period | 40.64% | 28.72% | +11.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.21% | 42.96% | +9.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.41% | 70.11% | -25.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.87% | 90.38% | -43.51% |
Dividends
KGC vs. AXSM - Dividend Comparison
KGC's dividend yield for the trailing twelve months is around 0.63%, while AXSM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KGC Kinross Gold Corporation | 0.63% | 0.44% | 1.29% | 1.98% | 2.93% | 2.69% | 0.82% |
Financials
KGC vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Kinross Gold Corporation and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KGC vs. AXSM - Profitability Comparison
KGC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kinross Gold Corporation reported a gross profit of 1.21B and revenue of 2.18B. Therefore, the gross margin over that period was 55.3%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
KGC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kinross Gold Corporation reported an operating income of 1.14B and revenue of 2.18B, resulting in an operating margin of 52.5%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
KGC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kinross Gold Corporation reported a net income of 822.76M and revenue of 2.18B, resulting in a net margin of 37.7%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
KGC and AXSM have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXSM has higher volatility (14.94%) compared to KGC (12.31%). In terms of maximum drawdown, KGC dropped -96.00% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KGC and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer